Compare Cardinal Health Inc (CAH) vs Intuit Inc. (INTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Intuit Inc. — how do they compare? Cardinal Health Inc trades at $231.36 (market cap $54.46B), while Intuit Inc. trades at $357.4 (market cap $91.56B). The key difference: Intuit Inc. is the larger of the two by market cap, and Intuit Inc. pays the higher dividend (1.43%). Which is the better fit depends on your goals.
| CAH | INTU | |
|---|---|---|
Market Cap | $54.46B | $91.56B |
Sector | Health | Technology |
52-Week High | $240.26 | $717.21 |
52-Week Low | $146.04 | $255.07 |
Enterprise Value | $58.49B | $90.01B |
Dividend Yield | 0.88% | 1.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $231.24, down 3.75% on the day, following a strong earnings beat in Q2 2026 with EPS of $2.91 versus $2.42 expected. The stock is in a bullish technical trend with moving averages supporting further upside, while fundamentals show robust revenue growth and improved profitability, with a net income margin of 0.67% for 2025. Recent news highlights record highs post-earnings and optimistic fiscal 2027 guidance.
The outlook for CAH is positive, driven by consistent earnings beats, strong analyst buy ratings (54.55%), and a consensus price target of $270.11 implying significant upside. Key risks include high leverage with a debt-to-asset ratio of 16.09 and reliance on pharmaceutical and specialty business segments for growth amidst competitive pressures.
Intuit (INTU) trades at $358.29, up 6.49% in the last session, with a bullish technical outlook supported by moving averages and strong support at $331. The company shows robust fundamentals, with revenue growing to $18.83B in 2025 and net income margin expanding to 20.54%, while consistently beating EPS estimates. Recent news highlights legal investigations into potential securities fraud following a 20% stock drop, creating mixed sentiment.
The outlook remains positive due to solid earnings growth and a consensus price target of $402.26, but risks include ongoing legal scrutiny and competitive pressures in financial software. Investors should weigh strong profitability against regulatory and sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →
